期刊文献+

血管紧张素1—7对高糖诱导人肾小管上皮细胞转分化的影响及其机制 被引量:1

Effect of angiotensin 1-7 on human renal proximal tubular epithelial cell transdifferentiationinduced by high glucose and its mechanism
原文传递
导出
摘要 目的研究血管紧张素1-7(Ang1-7)对高糖诱导人肾小管上皮细胞(HK-2)转分化的影响及其可能机制。方法培养HK一2细胞分组如下:对照组(N组)、高糖组(H组)、高糖+Ang 1-7组(A组)、高糖+Ang1-7+A779组(D组)、高糖+吡格列酮组(P组)。Western印迹检测各组HK一2细胞过氧化物酶体增殖物激活受体γ(PPAR-1)及α平滑肌肌动蛋白(α-SMA)的蛋白表达;实时定量PCR检测HK-2细胞PPAR-1及仅-SMA的mRNA表达;免疫荧光检测d.SMA表达。结果Ang1.7可上调高糖刺激下HK-2细胞PPAR.1蛋白及mRNA表达(P〈0.05);抑制高糖刺激的α-SMA蛋白及mRNA表达(P〈0.05)。这种作用与PPAR-1激动剂吡格列酮类似。给予Mas受体抑制剂A779后,Angl-7的上述作用可被部分抑制。结论Ang1-7在体外可通过上调PPAR.1表达,从而部分抑制高糖诱导的α-SMA表达,实现其抑制转分化的作用,而这种作用部分通过Mas受体所介导。 Objective To investigate the effect of angiotensin 1-7 (Ang 1-7) on renal proximal tubular epithelial cell (HK-2) transdifferentiation induced by high glucose. Methods All the raised HK-2 ceils were divided into 5 groups: normal control group, high glucose group, high glucose with Angl-7 group, high glucose with Angl-7 and A779 group, high glucose with pioglitazone group. Expression of peroxisome proliferator activated receptor-γ(PPAR-γ) and a-smooth muscle actin (α-SMA) was detected by Western blotting, real-time PCR and immunofluorescence. Results The levels of PPAR-γ protein and mRNA in HK-2 cells were significantly increased after treatment with high glucose and Ang 1-7. Expression of α-SMA protein and mRNA was inhibited remarkably after treatment with high glucose and Aug 1-7. These effects of Ang 1-7 on HK-2 cells could be reversed by Mas receptor antagonist A779. Conclusion Ang 1-7 inhibits high glucose-induced expression of α-SMA in HK-2 cells, which is in part through the Mas.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第12期903-906,共4页 Chinese Journal of Nephrology
关键词 血管紧张素1-7 过氧化物酶体增殖物激活受体-Γ 仪一平滑肌肌动蛋白 转分化 [Key words] Angiotensin-(1-7) Peroxisome proliferator activated receptor-γ cL-smoothmuscle actin Transdifferentiation
  • 相关文献

参考文献11

  • 1Burnier M,Zanchi A.Blockade of the renin-angiotensinaldosterone system:a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.J Hypertens,2006,24:11-25.
  • 2周巧玲 刘抗寒 Veeraragoo Pouranan 霍惠仪 袁明霞 肖舟 彭卫生.肾脏局部醛固酮对糖尿病肾病大鼠肾小管间质转分化的作用[J].中华肾脏病杂志,2010(5):364-369. 被引量:7
  • 3Dilauro M,Burns KD.Angiotensin-(1-7) and its effects in the kidney.Sci World J.2009,9:522-35.
  • 4Zimpelmann J, Burns KD. Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells.Am J Physiol Renal Physiol,2009,296:337-346.
  • 5Shenoy V,Ferreira AJ,Qi Y,et al.The ACE2/Ang-(1-7)/Mas axis cconfers cardiopulmonary protection against lung transdifferentiation and pulmonary hypertension.Am J Respir Crit Care Med,2010,182:1065-1072.
  • 6Lubel JS,Herath CB,Tchongue J,et al.Angiotensin-(1-7),an alternative metabolite of the renin-angiotensin system,is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.Clin Sci (Lond),2009,117:375-386.
  • 7Su Z,Zimpelmann J,Burns KD.Angiotensin-(l-7) inhibits angiotensin Ⅱ-stimulated phosphorylation of MAP kinases in proximal tubular cells.Kidney Int,2006,69:2212-2218.
  • 8Benter IF,Yousif MH,Dhaunsi GS,et al.Angiotensin-(1-7)prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.Am J Nephrol,2008,28:25-33.
  • 9Dhaunsi GS,Yousif MH,Akhtar S,et al.Angiotensin-(1-7)prevents diabetes-induced attenuation in PPAR-γ and catalase activities.Eur J Pharmacol,2010,638:108-114.
  • 10Kawai T,Masaki T,Doi S,et al.PPAR-gamma agonist attenuates renal interstitial transdifferentiation and inflammation through reduction of TGF-beta.Lab Invest,2009,89:47-58.

二级参考文献31

  • 1Cortinovis M,Perico N,Cattaneo D,et al.Aldosterone and progression of kidney disease.Ther Adv Cardiovasc Dis,2009,3:133-143.
  • 2Diah S,Zhang GX,Nagai Y,et al.Aldosterone induces myofibroblastic transdifferentiation and collagan gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells.Exp Cell Res,2008,314:3654-3662.
  • 3Zhang A,Jia Z,Guo X,et al.Aldosterone induces epithelial-mesenehymal transition via ROS of mitochondrial origin.Am J Physiol Renal Physiol,2007,293:F723-F731.
  • 4Fredersdorf S,Endemann DH,Luchner A,et al.Increased aldosterone levels in a model of type 2 diabetes mellitus.Exp Clin Endocrinol Diabetes,2009,117:15-20.
  • 5Ustundag B,Cay M,Naziroglu M,et al.The study of reninangiotensin-aldosterone in experimental diabetes mellitus.Cell Biochem Funct,1999,17:193-198.
  • 6Siragy HM,Xue C.Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats.Exp Physiol.2008.93:817-824.
  • 7Xue C,Siragy HM.Local renal aldosterone system and its regulation by salt,diabetes,and angiotensin Ⅱ type 1 receptor.Hypertension,2005,46:584-590.
  • 8Kiyomoto H,Rafiq K,Mostofa M,et al.Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.J Pharmacol Sci,2008,108:399-405.
  • 9O'Neill H,Lebeck J,Collins PB,et al.Aldosteronemediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitus.Nephrol Dial Transplant,2008,23:1546-1555.
  • 10Takebayashi K,Matsumoto S,Aso Y,et al.Aldosterone blockade attenuates urinary morlocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy.J Clin Endocrinol Metab,2006,91:2214-2217.

共引文献23

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部